Drug intelligence / Profile preview

opium tincture

Development stage
Phase 3
Lead developer
Marathon Pharmaceuticals
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Opium tincture** is an oral hydroalcoholic pharmaceutical preparation of opium, also called laudanum, standardized in U.S. deodorized products to contain 10 mg/mL anhydrous morphine equivalent. It is a Schedule II opioid preparation used as a nonspecific antidiarrheal; opioid agonism in the gastrointestinal tract increases intestinal smooth-muscle tone and suppresses propulsive contractions, thereby reducing stool frequency and fluid loss. U.S. labeling identifies diarrhea as its indication. Opium tincture has also been studied in Iran as opioid agonist treatment for opioid use disorder and was investigated by Marathon Pharmaceuticals in Phase 3 studies of chronic diarrhea associated with short bowel syndrome. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e2a5697a-cc41-4cf1-b3a8-59b0268740d7))

Brand names
Opii normataTinctura opii normata
Other names
laudanumtincture of opiumopii tincturamorphine tincturedeodorized opium tincture
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on opium tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on opium tincture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call